Search research articles
Contact Us
Filters
Showing results (41-50 of 107) with videos related to
Page
of 11
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2019
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume
Luca Ceriani, Lisa Milan, Peter W M Johnson, et al.
Haematologica
|
September 13, 2005
The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells
Silvia Coenen, Becky Pickering, Kathleen N Potter, et al.
British Journal of Haematology
|
February 21, 2006
Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma
Jorg Michels, Vipul Foria, Ben Mead, et al.
Current Biology : CB
|
July 18, 2003
Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription
Alexander H Mirnezami, Sandra J Campbell, Matthew Darley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519)
Peter W M Johnson, Matthew R Sydes, Barry W Hancock, et al.
Haematologica
|
September 24, 2009
Anti-CD20 monoclonal antibodies: historical and future perspectives
Sean H Lim, Stephen A Beers, Ruth R French, et al.
Blood
|
October 25, 2003
Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy
Yong Du, Jamie Honeychurch, Mark S Cragg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Comparison of outcomes in studies of advanced Hodgkin's lymphoma
Peter W M Johnson, John A Radford, Michael H Cullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions
Adam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Chemotherapy
|
August 22, 2012
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer
Simon J Crabb, Jennifer Bradbury, Luke Nolan, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 107) with videos related to
Sort By:
Page
of 11
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2019
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume
Luca Ceriani, Lisa Milan, Peter W M Johnson, et al.
Haematologica
|
September 13, 2005
The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells
Silvia Coenen, Becky Pickering, Kathleen N Potter, et al.
British Journal of Haematology
|
February 21, 2006
Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma
Jorg Michels, Vipul Foria, Ben Mead, et al.
Current Biology : CB
|
July 18, 2003
Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription
Alexander H Mirnezami, Sandra J Campbell, Matthew Darley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519)
Peter W M Johnson, Matthew R Sydes, Barry W Hancock, et al.
Haematologica
|
September 24, 2009
Anti-CD20 monoclonal antibodies: historical and future perspectives
Sean H Lim, Stephen A Beers, Ruth R French, et al.
Blood
|
October 25, 2003
Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy
Yong Du, Jamie Honeychurch, Mark S Cragg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2006
Comparison of outcomes in studies of advanced Hodgkin's lymphoma
Peter W M Johnson, John A Radford, Michael H Cullen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions
Adam Sharp, Simon J Crabb, Peter W M Johnson, et al.
Chemotherapy
|
August 22, 2012
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer
Simon J Crabb, Jennifer Bradbury, Luke Nolan, et al.
Page
of 11